Ownership history in CAXTON ASSOCIATES LP · 40 quarters on record
This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in Boston Scientific Corp Com (BSX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | ADDED | 701,105 | +1,105 | +0.2% | 1.97% | $62.6M | $89.32 |
| 2024 Q3 | ADDED | 700,000 | +650,000 | +1300.0% | 2.20% | $58.7M | $83.80 |
| 2022 Q4 | UNCHANGED | 50,000 | — | 0% | 0.15% | $2.3M | $46.27 |
| 2022 Q3 | REDUCED | 50,000 | -25,000 | -33.3% | 0.26% | $1.9M | $38.73 |
| 2020 Q3 | ADDED | 75,000 | +53,160 | +243.4% | 0.30% | $2.9M | $38.21 |
| 2019 Q1 | ADDED | 21,840 | +15,341 | +236.1% | 0.12% | $838K | $38.38 |
| 2018 Q3 | REDUCED | 6,499 | -38,476 | -85.5% | 0.02% | $250K | $38.50 |
| 2017 Q4 | ADDED | 44,975 | +24,875 | +123.8% | 0.05% | $1.1M | $24.79 |
| 2017 Q1 | REDUCED | 20,100 | -204,900 | -91.1% | 0.00% | $500K | $24.87 |
| 2015 Q1 | ADDED | 225,000 | +125,000 | +125.0% | 0.17% | $4.0M | $17.75 |
As of 2025 Q4 — sorted by position size